title: An epidemic of invasive fungal infection in a stem cell transplant unit; response to high-dose liposomal amphotericin B.
authors.forename: Clodagh
authors.initials: C
authors.lastname: Ryan
authors.forename: Siobhan
authors.initials: S
authors.lastname: McNicholsan
authors.forename: Brian
authors.initials: B
authors.lastname: O'Connell
authors.forename: Stephanie
authors.initials: S
authors.lastname: Forde
authors.forename: Mary
authors.initials: M
authors.lastname: Keoghan
authors.forename: Shaun R
authors.initials: SR
authors.lastname: McCann
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality; D002177:Candidiasis / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality; D003428:Cross Infection / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality; D004196:Disease Outbreaks; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006757:Hospital Units / Q000706:statistics & numerical data*; D006801:Humans; D007494:Ireland / Q000453:epidemiology; D008081:Liposomes; D009181:Mycoses / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality; D033581:Stem Cell Transplantation / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D000935:Antifungal Agents; D008081:Liposomes; D000666:Amphotericin B